175 related articles for article (PubMed ID: 34044829)
1. Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction.
Gao J; Yang YN; Cui Z; Feng SY; Ma J; Li CP; Liu Y
Lipids Health Dis; 2021 May; 20(1):56. PubMed ID: 34044829
[TBL] [Abstract][Full Text] [Related]
2. The relationship between protein convertase subtilisin kexin type-9 levels and extent of coronary artery disease in patients with non-ST-elevation myocardial infarction.
Dalgic Y; Abaci O; Kocas C; Cetinkal G; Dalgic SN; Buyuk A; Ser OS; Batit S; Arat A; Gurmen AT
Coron Artery Dis; 2020 Jan; 31(1):81-86. PubMed ID: 31206403
[TBL] [Abstract][Full Text] [Related]
3. PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction.
Zeller M; Lambert G; Farnier M; Maza M; Nativel B; Rochette L; Vergely C; Cottin Y
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):880-885. PubMed ID: 33546945
[TBL] [Abstract][Full Text] [Related]
4. Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Choi IJ; Lim S; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
Am J Cardiol; 2020 Oct; 133():54-60. PubMed ID: 32798044
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating proprotein convertase subtilisin/kexin type 9 levels and prognosis in patients with severe chronic kidney disease.
Rasmussen LD; Bøttcher M; Ivarsen P; Jørgensen HS; Nyegaard M; Buttenschøn H; Gustafsen C; Glerup S; Bøtker HE; Svensson M; Winther S
Nephrol Dial Transplant; 2020 Apr; 35(4):632-639. PubMed ID: 30137516
[TBL] [Abstract][Full Text] [Related]
6. Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study.
Cariou B; Guérin P; Le May C; Letocart V; Arnaud L; Guyomarch B; Pichelin M; Probst V
Diabetes Metab; 2017 Dec; 43(6):529-535. PubMed ID: 28865748
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions.
Wang S; Cheng ZY; Zhao ZN; Quan XQ; Wei Y; Xia DS; Li JQ; Hu JL
Eur Rev Med Pharmacol Sci; 2016; 20(6):1135-9. PubMed ID: 27049268
[TBL] [Abstract][Full Text] [Related]
8. Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study.
Li JJ; Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q
Medicine (Baltimore); 2015 Dec; 94(52):e2426. PubMed ID: 26717403
[TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography.
Panahi Y; Ghahrodi MS; Jamshir M; Safarpour MA; Bianconi V; Pirro M; Farahani MM; Sahebkar A
Clin Biochem; 2019 Dec; 74():12-18. PubMed ID: 31493378
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.
Bae KH; Kim SW; Choi YK; Seo JB; Kim N; Kim CY; Lee WK; Lee S; Kim JG; Lee IK; Lee JH; Park KG
Diabetes Metab J; 2018 May; ():. PubMed ID: 30112872
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.
Bae KH; Kim SW; Choi YK; Seo JB; Kim N; Kim CY; Lee WK; Lee S; Kim JG; Lee IK; Lee JH; Park KG
Diabetes Metab J; 2018 Jun; 42(3):207-214. PubMed ID: 29885102
[TBL] [Abstract][Full Text] [Related]
13. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
Hu D; Yang Y; Peng DQ
Int J Cardiol; 2017 Jan; 227():61-65. PubMed ID: 27846466
[TBL] [Abstract][Full Text] [Related]
14. Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.
Gao J; Wang HB; Xiao JY; Ren M; Reilly KH; Li YM; Liu Y
BMJ Open; 2018 Jul; 8(7):e021951. PubMed ID: 29991632
[TBL] [Abstract][Full Text] [Related]
15. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
[TBL] [Abstract][Full Text] [Related]
16. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
17. Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies.
Almontashiri NA; Vilmundarson RO; Ghasemzadeh N; Dandona S; Roberts R; Quyyumi AA; Chen HH; Stewart AF
PLoS One; 2014; 9(9):e106294. PubMed ID: 25180781
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
[TBL] [Abstract][Full Text] [Related]
19. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.
Werner C; Hoffmann MM; Winkler K; Böhm M; Laufs U
Vascul Pharmacol; 2014 Aug; 62(2):94-102. PubMed ID: 24685817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
